Login / Signup

Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract Cancer.

Gu-Wei JiKe WangYong-Xiang XiaJin-Song WangXue-Hao WangXiang-Cheng Li
Published in: Annals of surgical oncology (2020)
The immune signature promises to stratify prognosis and allocate treatment in resected BTC. The clinical-immune GBM models accurately predict recurrence and death from BTC following surgery.
Keyphrases